Delivery Order 36F79720D0148-36C26026F0062
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Harmony Biosciences LLC, a for-profit pharmaceutical company, to provide WAKIX 17.8 MG tablets. The $10,170 order was placed against the VA's Pharmaceuticals and Drugs Federal Supply Schedule contract to support the delivery of this narcolepsy medication to VA locations in Pittsburgh, Pennsylvania, with a completion date of March 29, 2024. No set-aside provisions were used for this...
- This federal contract award was issued by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The $10,170 firm-fixed-price delivery order is for WAKIX 17.8 MG, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract is issued against Harmony Biosciences' General Services...
- This federal contract award is for the delivery of WAKIX 17.8 MG tablets to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5. The $10,418.14 firm fixed price delivery order was awarded to Harmony Biosciences LLC, a for-profit pharmaceutical company that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The contract is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and supports...
- This federal contract award is a delivery order valued at $656,342.82 issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The award is for the bulk order of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. Harmony...
- Harmony Biosciences LLC was awarded a $10,170 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply WAKIX tablets. The delivery order was issued against the Pharmaceuticals and Drugs Federal Supply Schedule, also known as FSS-61-IB, with performance at the specified location in Plymouth Meeting, Pennsylvania and completion by March 2026. No set-aside provision was applied to this order to deliver...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a for-profit pharmaceutical company. The $702,527.44 contract is for the delivery of WAKIX 17.8 mg tablets and is issued under the VA's Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. Harmony Biosciences specializes in medications for rare neurological diseases and sleep disorders, with WAKIX being used to treat excessive daytime sleepiness and cataplexy in...
- Harmony Biosciences LLC has been awarded a firm fixed price delivery order valued at $10,170 to supply WAKIX 17.8 MG tablets. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 against the General Services Administration Federal Supply Schedule for Pharmaceuticals and Drugs. Performance will take place in Pittsburgh, Pennsylvania by January 31, 2024. No set-aside designation was applied to this order to fulfill...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company that specializes in medications for rare neurological diseases and sleep disorders. The contract is a Delivery Order under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, with a ceiling value of $10,418.14. The contract is for the supply of WAKIX 17.8 mg, a medication used to treat excessive daytime sleepiness and cataplexy in adult...
- Harmony Biosciences LLC has been awarded a firm fixed price delivery order valued at $10,170 to supply WAKIX 17.8 MG tablets. The order was issued against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5, with performance in Pittsburgh, Pennsylvania. No set-aside provision was applied to this order for WAKIX, which treats excessive daytime sleepiness and cataplexy in adult narcolepsy...
- The U.S. Department of Veterans Affairs (VA) awarded a $10,170 firm-fixed-price delivery order to Harmony Biosciences LLC for the pharmaceutical drug WAKIX 17.8MG 60 DOSES. This order is issued against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs. Harmony Biosciences is a for-profit pharmaceutical company that specializes in rare neurological diseases and sleep disorders. The delivery order has a period of...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79720D0148Federal Supply Schedule
- 36F79720D0148-36C26026F0062Delivery Order
The U.S. Department of Veterans Affairs Veterans Integrated Service Network 20 (VISN 20) awarded a delivery order to Harmony Biosciences LLC for the supply of bulk WAKIX 17.8 mg tablets, a pharmaceutical product used to treat excessive daytime sleepiness and cataplexy in narcolepsy patients. This firm fixed-price delivery order, valued at $619,879.33, was awarded on December 1, 2025, with a completion date of June 30, 2026, and will be performed in Pittsburgh, Pennsylvania. The award was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with no set-aside designation, indicating open competition among qualified vendors. This delivery order is issued under a larger $25 million Blanket Purchase Agreement between the VA National Acquisition Center and Harmony Biosciences LLC, which runs through June 2026 and streamlines the procurement of WAKIX across the VA healthcare system. Harmony Biosciences LLC, a pharmaceutical company headquartered in Plymouth Meeting, Pennsylvania, specializes in medications for rare neurological diseases and has established itself as a key supplier of WAKIX to multiple Veterans Integrated Service Networks nationwide. The company's federal contract portfolio demonstrates consistent delivery of this specialized pharmaceutical to support veteran healthcare needs across the VA system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $619.9k | 10/22/25 |